MRA Advisory Group Increases Holdings in Procter & Gamble Company (The) $PG

MRA Advisory Group raised its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 69.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,139 shares of the company’s stock after buying an additional 875 shares during the quarter. MRA Advisory Group’s holdings in Procter & Gamble were worth $341,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of PG. Northern Trust Corp increased its position in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after acquiring an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after acquiring an additional 583,629 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after acquiring an additional 1,018,865 shares during the last quarter. Finally, Royal Bank of Canada increased its position in Procter & Gamble by 0.6% during the first quarter. Royal Bank of Canada now owns 17,273,679 shares of the company’s stock valued at $2,943,779,000 after acquiring an additional 111,162 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG stock opened at $158.02 on Monday. The business has a fifty day moving average of $156.21 and a 200 day moving average of $161.77. The firm has a market capitalization of $369.85 billion, a price-to-earnings ratio of 24.27, a price-to-earnings-growth ratio of 4.17 and a beta of 0.36. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same period last year, the firm earned $1.40 EPS. The company’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble’s payout ratio is currently 64.82%.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Evercore ISI reiterated an “in-line” rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Wells Fargo & Company reduced their price objective on Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Barclays set a $164.00 price objective on Procter & Gamble and gave the stock an “equal weight” rating in a research note on Thursday, July 31st. Finally, BNP Paribas restated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $175.12.

Check Out Our Latest Research Report on Procter & Gamble

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 11,638 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the sale, the chief financial officer owned 52,642 shares of the company’s stock, valued at $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary A. Coombe sold 10,194 shares of the business’s stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares of the company’s stock, valued at approximately $5,532,120.48. This trade represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is owned by company insiders.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.